10159- SPDR-4 A RUNX1 SWITCH-OFF APPROACH INHIBITS THE PIF1-P21 AXIS, ONE OF THE MECHANISMS OF GLIOBLASTOMA MALIGNANCY MAINTENANCE

Etsuko Yamamoto, Tatsuya Masuda, Yasuzumi Matsui, Youhei Mineharu, Yasuhide Makino, Shigeki Takada, Noritaka Sano, Masahiro Tannji, Yasuhiko Kamikubo, Hiroshi Sugiyama, Yoshiki Arakawa · 2024

Read 10159- SPDR-4 A RUNX1 SWITCH-OFF APPROACH INHIBITS THE PIF1-P21 AXIS, ONE OF THE MECHANISMS OF GLIOBLASTOMA MALIGNANCY MAINTENANCE by Etsuko Yamamoto, Tatsuya Masuda, Yasuzumi Matsui, Youhei Mineharu, Yasuhide Makino, Shigeki Takada, Noritaka Sano, Masahiro Tannji, Yasuhiko Kamikubo, Hiroshi Sugiyama, Yoshiki Arakawa (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605587.txt.

Description

Yamamoto and ten co-authors report a study from twenty twenty-four on a hard brain tumor called glioblastoma. The tumor is hard to treat, and long survival stays rare even with mixed care. The team asks how a gene switch called RUNX1 helps the tumor stay harmful. They test a drug that blocks the RUNX group and turns RUNX1 down in tumor cells.

Lab tests and tests in mice show RUNX1 turns on a second gene, PIF1, which holds down a brake gene called p21. When the drug blocks RUNX1, tumors in mice shrank and the mice lived longer. The drug also built up in tumors more than in healthy tissue. The work points to a new drug path for this tumor.

Catalog record

CREATOREtsuko Yamamoto, Tatsuya Masuda, Yasuzumi Matsui, Youhei Mineharu, Yasuhide Makino, Shigeki Takada, Noritaka Sano, Masahiro Tannji, Yasuhiko Kamikubo, Hiroshi Sugiyama, Yoshiki Arakawa
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11605587

Browse the full library · About the Tower of Babel